The phosphodiesterase-4 inhibitor roflumilast, a potential treatment for the comorbidity of memory loss and depression in Alzheimerâs disease: a preclinical study in APP/PS1 transgenic mice
Wang, Hao, Zhang, Fang-fang, Xu, Yong, Fu, Hua-rong, dan Wan, Xiao-, Wang, Lei, Chen, Wei, Xu, Xiao-yan, Gao, Yong-feng, Zhang, Ji-guo, Zhang, Han-TingJournal:
International Journal of Neuropsychopharmacology
DOI:
10.1093/ijnp/pyaa048
Date:
July, 2020
Fichier:
PDF, 1.67 MB
2020